Latest News about GILD
Recent news which mentions GILD
From Benzinga
From Motley Fool
From Benzinga
These 2 Growth Stocks Have Potential Catalysts on the Way
October 12, 2022
From Motley Fool
Want to Collect 4% in Dividends Every Month? Buy These 3 Stocks
October 12, 2022
From Motley Fool
4 Biotech Stocks With Huge Incoming Catalysts
October 12, 2022
From Motley Fool
Gilead's Trodelvy Under FDA Review For Pre-Treated HR+/HER2- Metastatic Breast Cancer
October 11, 2022
Tickers
GILD
From Benzinga
How to Find Stocks That Rise 10x
October 10, 2022
From InvestorPlace
Why This Gilead Analyst Believes The Stock Is Highly Undervalued
October 04, 2022
Tickers
GILD
From Benzinga
2 Top Biotech Stocks to Buy for the Long Haul
October 02, 2022
From Motley Fool
3 Biotech Stocks to Sell in October
September 29, 2022
From InvestorPlace
Vietnam Law May Impact Facebook, Twitter; Amazon Has A Sleep Tracker; India Lures Apple, Dell, HP: Top Financial Media Stories Thursday, Sept. 29
September 29, 2022
From Benzinga
Gilead's Investigation Reveals Two Kingpins Directly Associated With Fake HIV Medications Scheme
September 29, 2022
Tickers
GILD
From Benzinga
7 Monthly Dividend Stocks to Buy for Safety
September 29, 2022
From InvestorPlace
The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market
September 27, 2022
From InvestorPlace
Got $1,000? 2 Stocks That Could Be Bargain Buys For 2022 and Beyond
September 23, 2022
From Motley Fool
Here's How Much $100 Invested In Gilead Sciences 15 Years Ago Would Be Worth Today
September 20, 2022
Tickers
GILD
From Benzinga
Merck To Start New Islatravir HIV Trials With Lower Dose After FDA Hold
September 20, 2022
From Benzinga
"The Era of the Gene-Edited Human Is Here"
September 19, 2022
From Motley Fool
NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly
September 19, 2022
From Benzinga
7 Penny Stocks That Actually Have a Buy Rating
September 19, 2022
From InvestorPlace
Europe may give COVID vaccines full marketing authorization to avoid annual review, and WHO backs Gilead’s Veklury for severe disease
September 16, 2022
From MarketWatch
WHO Recommends Gilead's COVID-19 Therapy For Severe Disease
September 16, 2022
Tickers
GILD
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 15, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.